BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  GSK Makes $2B Play to Challenge Merck in Chronic Cough Market

  The acquisition of Bellus Health will give GSK access to camlipixant, a potentially best-in-class P2X3 antagonist for chronic cough.

  April 18, 2023

   · 

  3 min read

   · 

  Tristan Manalac
• 

  FDA

  Gamida’s Long Regulatory Road Ends in Approval of Blood Cancer Cell Therapy

  Omisirge is approved for patients who receive cord blood transplantation following myeloablative therapy.

  April 18, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Merck’s Keytruda Scores Triple Hit at AACR

  The checkpoint inhibitor improved patient outcomes in three cancer trials, according to results presented at the AACR meeting.

  April 18, 2023

   · 

  4 min read

   · 

  Holly Barker
• 

  Drug Development

  FDA Adcomm Backs Innoviva’s Pneumonia Antibiotic

  A unanimous FDA committee vote supported the favorable risk-benefit profile of Innoviva’s sulbactam-durlobactam for hospital-acquired A. baumannii infections.

  April 18, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• Genetown

  Biophytis: Results of the Combined General Meeting on April 17, 2023

  Biophytis SA announces the approval by a very large majority of all resolutions presented by the company and falling within the remit of the Combined General Meeting.

  April 18, 2023

   · 

  4 min read
• Carbios Accelerates Its Enzyme Optimization With Screening Capabilities for Millions of Enzymes in a Day

  Carbios has accelerated its enzyme screening process with a microfluidic technology developed in partnership with the Paul Pascal Research Centre.

  April 18, 2023

   · 

  6 min read
• Policy

  Basilea provides update on New Drug Application to the US Food and Drug Administration for antibiotic ceftobiprole

  Basilea Pharmaceutica Ltd provided an updated timeline for its New Drug Application submission for its antibiotic ceftobiprole to the US Food and Drug Administration.

  April 18, 2023

   · 

  4 min read
• argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting

  argenx SE announced that it will present six abstracts further demonstrating its long-term commitment to the generalized myasthenia gravis community during the 75th American Academy of Neurology Annual Meeting, which is taking place from April 22-27, 2023 in Boston, MA.

  April 18, 2023

   · 

  9 min read
• BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR

  BerGenBio ASA announced that it presented data linking AXL activation to STK11 loss of function in Non-Small Cell Lung Cancer in an abstract titled, AXL as a Therapeutic Target in STK11 mutant NSCLC, at the American Association for Cancer Research Annual Meeting 2023.

  April 18, 2023

   · 

  3 min read
• Drug Development

  OSE Immunotherapeutics Presents Clinical and Preclinical Data from its Immuno-Oncology Portfolio

  OSE Immunotherapeutics SA announces three presentations at the American Association for Cancer Research Annual Meeting in Orlando, April 14-19, 2023.

  April 18, 2023

   · 

  11 min read